WallStreetZenWallStreetZen

NYSE: NVST
Envista Holdings Corp Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for NVST

Based on 9 analysts offering 12 month price targets for Envista Holdings Corp

Min Forecast
$21.00-8.3%
Avg Forecast
$28.33+23.72%
Max Forecast
$33.00+44.1%

Should I buy or sell NVST stock?

Based on 10 analysts offering ratings for Envista Holdings Corp.

Buy
Strong Buy
2 analysts 20%
Buy
2 analysts 20%
Hold
6 analysts 60%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Our proven Zen Rating quant model agrees with analyst consensus with a "Buy" rating. Learn More

Be the first to know when Wall Street analysts revise their NVST stock forecasts and price targets.

NVST stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-10-15
lockedlocked$00.00+00.00%2026-10-14
lockedlocked$00.00+00.00%2026-10-09
lockedlocked$00.00+00.00%2026-09-28
lockedlocked$00.00+00.00%2026-09-18
Needham
Top 24%
77
HoldReiteratesN/AN/A2026-09-18
JP Morgan
Top 44%
57
Strong BuyUpgrades$32.00+39.74%2026-09-03
Barclays
Top 28%
73
Strong BuyMaintains$32.00+39.74%2026-06-11
Evercore ISI Group
Top 15%
86
BuyMaintains$33.00+44.10%2026-05-07
Morgan Stanley
Top 5%
96
HoldMaintains$21.00-8.30%2026-04-24

1 of 1

Forecast return on equity

Is NVST forecast to generate an efficient return?

Company
10.15%
Industry
23.94%
Market
177.77%
NVST's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is NVST forecast to generate an efficient return on assets?

Company
5.58%
Industry
17.48%
NVST is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

NVST earnings per share forecast

What is NVST's earnings per share in the next 3 years based on estimates from 18 analysts?

Avg 1 year Forecast
$1.56+164.63%
Avg 2 year Forecast
$1.70+187.41%
Avg 3 year Forecast
$1.85+213.05%
NVST's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

NVST revenue forecast

What is NVST's revenue in the next 3 years based on estimates from 18 analysts?

Avg 1 year Forecast
$2.9B+2.78%
Avg 2 year Forecast
$3.0B+6.42%
Avg 3 year Forecast
$3.2B+10.83%
NVST's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

NVST earnings growth forecast

How is NVST forecast to perform vs Medical Instruments & Supplies companies and vs the US market?

Company
46.2%
Industry
28.84%
Market
32.78%
NVST's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
NVST's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
NVST's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

NVST revenue growth forecast

How is NVST forecast to perform vs Medical Instruments & Supplies companies and vs the US market?

Company
3.44%
Industry
8.35%
Market
14.13%
NVST's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
NVST's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

NVST vs Medical Stocks

TickerPricePrice TargetUp/downsideConsensus
NVST$22.90$28.33+23.72%Buy
ICUI$162.99$191.00+17.19%Strong Buy
PLSE$44.43$63.80+43.60%Strong Buy
WRBY$23.34$31.00+32.82%Strong Buy
ATRC$56.07$57.71+2.93%Strong Buy
View Top Medical Stocks

Envista Holdings Stock Forecast FAQ

Is Envista Holdings Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 10 Wall Street analysts covering (NYSE: NVST) stock is to Buy NVST stock.

Out of 10 analysts, 2 (20%) are recommending NVST as a Strong Buy, 2 (20%) are recommending NVST as a Buy, 6 (60%) are recommending NVST as a Hold, 0 (0%) are recommending NVST as a Sell, and 0 (0%) are recommending NVST as a Strong Sell.

If you're new to stock investing, here's how to buy Envista Holdings stock.

What is NVST's earnings growth forecast for 2026-2028?

(NYSE: NVST) Envista Holdings's forecast annual earnings growth rate of 46.2% is forecast to beat the US Medical Instruments & Supplies industry's average forecast earnings growth rate of 28.84%, and it is also forecast to beat the US market's average forecast earnings growth rate of 32.78%.

Envista Holdings's earnings in 2026 is $95,000,000.On average, 18 Wall Street analysts forecast NVST's earnings for 2026 to be $250,772,429, with the lowest NVST earnings forecast at $236,108,032, and the highest NVST earnings forecast at $263,091,807. On average, 18 Wall Street analysts forecast NVST's earnings for 2027 to be $272,359,449, with the lowest NVST earnings forecast at $250,274,514, and the highest NVST earnings forecast at $296,821,526.

In 2028, NVST is forecast to generate $296,660,909 in earnings, with the lowest earnings forecast at $267,589,103 and the highest earnings forecast at $333,924,217.

What is NVST's revenue growth forecast for 2026-2028?

(NYSE: NVST) Envista Holdings's forecast annual revenue growth rate of 3.44% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 8.35%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 14.13%.

Envista Holdings's revenue in 2026 is $2,856,500,000.On average, 18 Wall Street analysts forecast NVST's revenue for 2026 to be $471,573,593,624, with the lowest NVST revenue forecast at $451,175,144,581, and the highest NVST revenue forecast at $487,474,746,815. On average, 18 Wall Street analysts forecast NVST's revenue for 2027 to be $488,277,835,360, with the lowest NVST revenue forecast at $460,490,971,703, and the highest NVST revenue forecast at $515,743,463,599.

In 2028, NVST is forecast to generate $508,515,666,694 in revenue, with the lowest revenue forecast at $475,428,418,640 and the highest revenue forecast at $544,815,268,928.

What is NVST's forecast return on assets (ROA) for 2026-2029?

(NYSE: NVST) forecast ROA is 5.58%, which is lower than the forecast US Medical Instruments & Supplies industry average of 17.48%.

What is NVST's Price Target?

According to 9 Wall Street analysts that have issued a 1 year NVST price target, the average NVST price target is $28.33, with the highest NVST stock price forecast at $33.00 and the lowest NVST stock price forecast at $21.00.

On average, Wall Street analysts predict that Envista Holdings's share price could reach $28.33 by Oct 15, 2027. The average Envista Holdings stock price prediction forecasts a potential upside of 23.72% from the current NVST share price of $22.90.

What is NVST's Earnings Per Share (EPS) forecast for 2026-2028?

(NYSE: NVST) Envista Holdings's current Earnings Per Share (EPS) is $0.59. On average, analysts forecast that NVST's EPS will be $1.56 for 2026, with the lowest EPS forecast at $1.47, and the highest EPS forecast at $1.64. On average, analysts forecast that NVST's EPS will be $1.70 for 2027, with the lowest EPS forecast at $1.56, and the highest EPS forecast at $1.85. In 2028, NVST's EPS is forecast to hit $1.85 (min: $1.67, max: $2.08).

What is NVST's forecast return on equity (ROE) for 2026-2029?

(NYSE: NVST) forecast ROE is 10.15%, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.